Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Blanchette, Lisa M.
Kuti, Joseph L.
Nicolau, David P.
and
Nailor, Michael D.
2014.
Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae.
Scandinavian Journal of Infectious Diseases,
Vol. 46,
Issue. 11,
p.
803.
Curran, Evonne T
and
Otter, Jonathan A
2014.
Outbreak Column 15: Carbapenemase-producing Enterobacteriaceae.
Journal of Infection Prevention,
Vol. 15,
Issue. 5,
p.
193.
Andria, Nizar
Henig, Oryan
Kotler, Offer
Domchenko, Alexander
Oren, Ilana
Zuckerman, Tsila
Ofran, Yishai
Fraser, Drora
and
Paul, Mical
2015.
Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
Journal of Antimicrobial Chemotherapy,
Vol. 70,
Issue. 11,
p.
3146.
Hagiya, Hideharu
Ogawa, Hiroko
Takahashi, Yusuke
Yamamoto, Akira
and
Otsuka, Fumio
2015.
<i>Klebsiella oxytoca</i>-producing IMP-1 Detected as the First Strain of Carbapenem-resistant <i>Enterobacteriaceae</i> in Our Hospital.
Internal Medicine,
Vol. 54,
Issue. 22,
p.
2939.
Taşova, Yeşim
2015.
Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infection: A Serious Threat in ICUs.
Medical Science Monitor,
Vol. 21,
Issue. ,
p.
219.
Woods, Robert J.
and
Read, Andrew F.
2015.
Clinical management of resistance evolution in a bacterial infection.
Evolution, Medicine, and Public Health,
Vol. 2015,
Issue. 1,
p.
281.
Ling, Moi Lin
Tee, Yong Ming
Tan, Soong Geck
Amin, Ismawati M.
How, Kue Bien
Tan, Kwee Yuen
and
Lee, Lai Chee
2015.
Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore.
Antimicrobial Resistance and Infection Control,
Vol. 4,
Issue. 1,
Tang, Hung-Jen
Hsieh, Cheng-Fang
Chang, Ping-Chin
Chen, Jyh-Jou
Lin, Yu-Hsiu
Lai, Chih-Cheng
Chao, Chien-Ming
Chuang, Yin-Ching
and
Zhou, Dongsheng
2016.
Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates.
PLOS ONE,
Vol. 11,
Issue. 3,
p.
e0151897.
Bar-Yoseph, Haggai
Hussein, Khetam
Braun, Eyal
and
Paul, Mical
2016.
Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.
Journal of Antimicrobial Chemotherapy,
Vol. 71,
Issue. 10,
p.
2729.
Chari, Priyadarshini
Seruga, Anna
Nathan, Nelson
and
Bowers, David M
2016.
The growing threat of carbapenem resistant enterobacteriaceae (CRE) within in-patient spinal rehabilitation units.
Spinal Cord Series and Cases,
Vol. 2,
Issue. 1,
Al-Agamy, Mohamed H.
El Mahdy, Taghrid S.
and
Shibl, Atef M.
2016.
Fecal Colonization with Extended-Spectrum Beta-Lactamase and AmpC-ProducingEscherichia coli.
BioMed Research International,
Vol. 2016,
Issue. ,
p.
1.
Welfare, William
Decraene, Valerie
Cleary, Paul
Dodgson, Andrew
and
Puleston, Richard
2016.
Screening for carbapenemase-producing Enterobacteriaceae-issues for consideration.
Journal of Infection,
Vol. 72,
Issue. 2,
p.
260.
Adler, Amos
Friedman, N. Deborah
and
Marchaim, Dror
2016.
Multidrug-Resistant Gram-Negative Bacilli.
Infectious Disease Clinics of North America,
Vol. 30,
Issue. 4,
p.
967.
van Duin, David
and
Paterson, David L.
2016.
Multidrug-Resistant Bacteria in the Community.
Infectious Disease Clinics of North America,
Vol. 30,
Issue. 2,
p.
377.
Prasad, Nishant
Labaze, Georges
Kopacz, Joanna
Chwa, Sophie
Platis, Dimitris
Pan, Cynthia X.
Russo, Daniel
LaBombardi, Vincent J.
Osorio, Giuliana
Pollack, Simcha
Kreiswirth, Barry N.
Chen, Liang
Urban, Carl
and
Segal-Maurer, Sorana
2016.
Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City.
American Journal of Infection Control,
Vol. 44,
Issue. 5,
p.
525.
Bartsch, Sarah M.
Huang, Susan S.
Wong, Kim F.
Slayton, Rachel B.
McKinnell, James A.
Sahm, Daniel F.
Kazmierczak, Krystyna
Mueller, Leslie E.
Jernigan, John A.
Lee, Bruce Y.
and
Diekema, D. J.
2016.
Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.
Journal of Clinical Microbiology,
Vol. 54,
Issue. 11,
p.
2757.
Cunha, Cheston B.
Kassakian, Steven Z.
Chan, Ryan
Tenover, Fred C.
Ziakas, Panos
Chapin, Kimberle C.
and
Mermel, Leonard A.
2016.
Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
American Journal of Infection Control,
Vol. 44,
Issue. 2,
p.
126.
DalBen, Mirian de Freitas
Teixeira Mendes, Elisa
Moura, Maria Luisa
Abdel Rahman, Dania
Peixoto, Driele
Alves dos Santos, Sania
Barcelos de Figueiredo, Walquiria
Vitale Mendes, Pedro
Utino Taniguchi, Leandro
Bezerra Coutinho, Francisco Antonio
Massad, Eduardo
and
Levin, Anna Sara
2016.
A Model-Based Strategy to Control the Spread of Carbapenem-Resistant Enterobacteriaceae: Simulate and Implement.
Infection Control & Hospital Epidemiology,
Vol. 37,
Issue. 11,
p.
1315.
Dickstein, Y.
Edelman, R.
Dror, T.
Hussein, K.
Bar-Lavie, Y.
and
Paul, M.
2016.
Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
Journal of Hospital Infection,
Vol. 94,
Issue. 1,
p.
54.
Poole, K.
George, R.
Decraene, V.
Shankar, K.
Cawthorne, J.
Savage, N.
Welfare, W.
and
Dodgson, A.
2016.
Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization.
Journal of Hospital Infection,
Vol. 94,
Issue. 2,
p.
125.